In the medium to long-term, it's clear we will see more M&A activity so China can make good on its goal of becoming more globally relevant, some Chinese companies have been restricted in the purchase of (foreign exchange) FX ... Against such a backdrop, it's clear the Syngenta acquisition is a strategic priority with support from the very top.